CD8A and neoplasm: Granzyme-B, the functional marker of CD8+ T cells, was also increased in the combination treatment groups (Figure 5B), indicating that VPA/HPTA activated the CD8+ T cells and thus enhanced the RT effect in the tumor, which may be associated with IL-12 secreted by anti-tumor M1-type macrophages.